While CR1 and CLU represent the most robust and consistently replicated complement-related genetic risk loci in AD, several additional complement genes have been suggested by candidate gene studies, rare variant analyses, or pathway-level enrichment analyses. The gene discussed is CLU; the disease is Alzheimer disease.